The uncomfortable truth? Many founders become the bottleneck. Not because they lack capability, but because they have not made the internal shift from tactical operator to strategic leader. While ...
As Gregor Hohpe notes in Platform Strategy: Innovation Through Harmonization, weak platforms resemble a fruit salad. They're ...
In June 2025, the FDA granted Fast Track designation to nuvisertib, a PIM1 kinase inhibitor from Sumitomo Pharma, for ...
In April 2025, AstraZeneca announced that its experimental oral PCSK9 inhibitor, AZD0780, achieved a 50.7% reduction in LDL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback